Literature DB >> 11730941

Substance P enhances HIV-1 replication in latently infected human immune cells.

Y Li1, S D Douglas, L Song, S Sun, W Z Ho.   

Abstract

Substance P (SP) is a potent modulator of neuroimmunoregulation. SP receptors are present on human monocytes and T lymphocytes, and SP alters the function of these immune cells. We investigated the effects of SP on HIV-1 replication in latently infected human immune cells. SP significantly enhanced HIV-1 replication in the latently infected promonocytic cell line (U1) and T lymphocyte line (ACH-2) stimulated with tumor necrosis factor (TNF-alpha). When added to these cells in combination with TNF-alpha, SP also enhanced HIV-1 gag gene expression in U1 and ACH-2 cells. This stimulatory effect of SP was associated with the activation of HIV-LTR (long terminal repeat) driven chloramphenicol acetyltransferase (CAT) gene expression, and could be blocked by pretreatment of U1 and ACH-2 cells with an SP receptor antagonist RP-67,580, indicating specific SP receptor-mediated regulation. Furthermore, the addition of SP to the cultures of latently infected peripheral blood mononuclear cells isolated from HIV-1-infected patients enhanced HIV-1 gag gene expression. Thus, SP may play a potentially important role as a positive regulator of HIV-1 replication in latently infected monocytes and lymphocytes. These observations may have significant implications toward understanding the role of neuropeptide SP in the immunopathogenesis of HIV-1 infection and AIDS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730941     DOI: 10.1016/s0165-5728(01)00439-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.

Authors:  Mark M Manak; Dmitry A Moshkoff; Lequan T Nguyen; John Meshki; Pablo Tebas; Florin Tuluc; Steven D Douglas
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

2.  Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA.

Authors:  Jian-Ping Lai; Steven D Douglas; Yan-Jian Wang; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

3.  Neurokinin-1 receptor (NK1-R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNS.

Authors:  Heather Vinet-Oliphant; Xavier Alvarez; Elizabeth Buza; Juan T Borda; Mahesh Mohan; Pyone P Aye; Florin Tuluc; Steven D Douglas; Andrew A Lackner
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

4.  Varicella Zoster Virus Induces Nuclear Translocation of the Neurokinin-1 Receptor, Promoting Lamellipodia Formation and Viral Spread in Spinal Astrocytes.

Authors:  Andrew N Bubak; Christina N Como; Anna M Blackmon; Seth Frietze; Teresa Mescher; Dallas Jones; Randall J Cohrs; Petr Paucek; Nicholas L Baird; Maria A Nagel
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 5.226

5.  An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.

Authors:  Xu Wang; Steven D Douglas; Jin-Song Peng; Dun-Jin Zhou; Qi Wan; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

6.  Substance P is required for the pathogenesis of EMCV infection in mice.

Authors:  Prema Robinson; Armandina Garza; Jeffrey Moore; T Kris Eckols; Skakun Parti; Vishwanathan Balaji; Jesus Vallejo; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2009-03-31

7.  Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.

Authors:  Tzong-Shi Lu; Hava Karsenty Avraham; Seyha Seng; Souvenir D Tachado; Henry Koziel; Alexandros Makriyannis; Shalom Avraham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.

Authors:  Sergei Spitsin; Florin Tuluc; John Meshki; Jian Ping Lai; Richard Tustin Iii; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2013-07-05       Impact factor: 2.492

9.  Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophages.

Authors:  Xu Wang; Steven D Douglas; Li Song; Yan-Jian Wang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-25       Impact factor: 4.147

10.  Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.

Authors:  Sergei Spitsin; Pablo Tebas; Jeffrey S Barrett; Vasiliki Pappa; Deborah Kim; Deanne Taylor; Dwight L Evans; Steven D Douglas
Journal:  JCI Insight       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.